Providence Therapeutics Holdings Inc
Providence Therapeutics Enrolls First Patient in World's First Clinical Trial of a Personalized mRNA Vaccine for Pediatric Brain Cancer
Providence Therapeutics, Inc., a clinical-stage biotechnology company specializing in messenger RNA (mRNA) vaccines, today announced that enrolment…